Amylin/calcitonin receptor (dual) drugs for Obesity

4 tracked Amylin/calcitonin receptor (dual) drugs in the Obesity race. The class explanation lives on the Amylin/calcitonin receptor (dual) page; the full indication pipeline across every mechanism is on the Obesity page.

3 Phase 31 Phase 2

Head-to-head evidence: BGM1812 vs cagrilintide · BGM1812 vs cagrilintide/semaglutide · BGM1812 vs petrelintide · cagrilintide vs cagrilintide/semaglutide · cagrilintide vs petrelintide · cagrilintide/semaglutide vs petrelintide

The roster

← all Amylin/calcitonin receptor (dual) drugs